Robert Fontana (@robertfontanamd) 's Twitter Profile
Robert Fontana

@robertfontanamd

Professor & Director of #Liver #Transplant @MichiganLiver @UMichMedicine

ID: 1262047459905175552

linkhttps://bit.ly/2WD0z7l calendar_today17-05-2020 15:49:03

131 Tweet

447 Followers

57 Following

Robert Fontana (@robertfontanamd) 's Twitter Profile Photo

Unbelievably rapid identification of the putative hepatotoxin. We should have heightened alert for future cases from plant base proteins as these are more widely used in lieu of animal protein. Really enjoyed the presentations!! Michigan Hepatology Liver Fellow Network AASLD

Robert Fontana (@robertfontanamd) 's Twitter Profile Photo

Using ipsc derived hepatocytes should overcome a lot of prior limitations of primary cells. MPs with flow enhance function and get us closer to in Vivo environment. Really excited to be a part of this cutting edge work !!! Michigan Hepatology Liver Fellow Network AASLD EdinClinTox

Robert Fontana (@robertfontanamd) 's Twitter Profile Photo

We can move the field forward and help our patients in their journey to improved liver health by using FDA approved meds for AUD. Start low and go slow and use alcohol biomarkers to guide the way…..

Robert Fontana (@robertfontanamd) 's Twitter Profile Photo

My sense is that this is the ultimate team sport. PCP’s are in the frontline of the 20-30% of population with masld. It is critical for all practitioners to know about biomarkers for. Risk stratification so that high risk can be triaged for the growing # of treatments

Robert Fontana (@robertfontanamd) 's Twitter Profile Photo

1st case of Tirzepatide DILI !!! GLP-1 agonist--> wt loss & improve MASLD but ? hepatic AE. 64 y.o. M hepatitis + jaundice at wk 6 of Rx. Bx--> patchy centrilob injury, duct rxn @Livertox @Liverfellow Michigan Hepatology Lily Dara 10.1016/j.cgh.2024.06.025

Robert Fontana (@robertfontanamd) 's Twitter Profile Photo

COVID Vaccines & DILI? 16 cases of mRNA Vaccines acute hep at 16 d. 75% hepatocellular, 37% jaundice; 88% resolve by mon 6; steroids in 37%. ↑ERAP-1/ERAP-2 variants. Michigan Hepatology Bruce Sanderson PMID: 38314748 DOI: 10.14309/ajg.0000000000002702

COVID      Vaccines &amp; DILI? 16 cases of      mRNA Vaccines acute hep at 16 d. 75% hepatocellular, 37% jaundice; 88%      resolve by mon 6; steroids in 37%. ↑ERAP-1/ERAP-2 variants. <a href="/MichiganLiver/">Michigan Hepatology</a>  <a href="/lilydara/">Bruce Sanderson</a> PMID: 38314748 DOI: 10.14309/ajg.0000000000002702
Robert Fontana (@robertfontanamd) 's Twitter Profile Photo

HDS Botanicals in the US: > 15 million Americans take potentially hepatotoxic HDS botanicals every Day ! Most self-initiated to “Boost Immunity or Energy” doi:10.1001/jamanetworkopen.2024.25822 Michigan Hepatology LiverTox Michigan Medicine

HDS Botanicals in the US: &gt; 15 million Americans take potentially hepatotoxic HDS botanicals every Day ! Most self-initiated to “Boost Immunity or Energy” doi:10.1001/jamanetworkopen.2024.25822 <a href="/MichiganLiver/">Michigan Hepatology</a> <a href="/livertox/">LiverTox</a> <a href="/umichmedicine/">Michigan Medicine</a>
Robert Fontana (@robertfontanamd) 's Twitter Profile Photo

Very excited about this new high thru-put platform to accelerate DILI research. Viability to 28d will provide improved simulation of human DILI and co-factors. GO BLUE !!! Liver Fellow Network LiverTweet EdinClinTox Einar S. Björnsson

LiverTox (@livertox) 's Twitter Profile Photo

The Dream Team! DILIN Steering Committee Face to Face Meeting in Washington DC- October 7, 2024 Shaping the future in DILI research and prevention

The Dream Team!
DILIN Steering Committee Face to Face Meeting in Washington DC- October 7, 2024

Shaping the future in DILI research and prevention
Lily Dara (@lilydaramd) 's Twitter Profile Photo

Kudos to Robert Fontana and jonnysexton for pulling off a very successful Hepatotoxicity SIG session on organoids at #tlm2024! Cutting edge tools to study liver disease and DILI! AASLD

Kudos to <a href="/RobertFontanaMD/">Robert Fontana</a> and <a href="/jonnysexton/">jonnysexton</a> for pulling off a very successful Hepatotoxicity SIG session on organoids at #tlm2024! Cutting edge tools to study liver disease and DILI! <a href="/AASLDtweets/">AASLD</a>
Robert Fontana (@robertfontanamd) 's Twitter Profile Photo

Thx so much for warm hospitality & weather at Loma linda liver grand rounds. Great facility &program. Fun to catch up with Andy w. And Mina !!! LiverTox Michigan Medicine

Thx so much for warm hospitality &amp; weather at Loma linda liver grand rounds. Great facility &amp;program.  Fun to catch up with Andy w.  And Mina !!! <a href="/livertox/">LiverTox</a> <a href="/umichmedicine/">Michigan Medicine</a>
Robert Fontana (@robertfontanamd) 's Twitter Profile Photo

I learned a lot from my esteemed colleagues. Alf patient outcomes continue to improve with better diagnostics, early CTRRT, less blood products.and more thoughtful use of txp. It takes a village for rare diseases!! Liver Fellow Network UMichGIHep-Fellowship LiverTox